Mattia Ferro

Prof. Mattia Ferro

Department of Psychology, Sigmund Freud University, 20143 Milan, Italy

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2017 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
Elena CriscuoloElena Criscuolo
Elena Criscuolo
Sara SpadiniSara Spadini
Sara Spadini
JLJacopo Lamanna
Jacopo Lamanna
MFMattia Ferro
Mattia Ferro
RBRoberto Burioni
Roberto Burioni
Bacteriophage therapy dates back almost a century, but the discovery of antibiotics led to a rapid decline in the interests and investments within this field of research. Recently, the novel threat of multidrug-resistant bacteria highlighted the alarming drop in research and development of new antibiotics: 16 molecules were discovered during 1983–87, 10 new therapeutics during the nineties, and only 5 between 2003 and 2007. Phages are therefore being reconsidered as alternative therapeutics. Phage display technique has proved to be extremely promising for the identification of effective antibodies directed against pathogens, as well as for vaccine development. At the same time, conventional phage therapy uses lytic bacteriophages for treatment of infections and recent clinical trials have shown great potential. Moreover, several other approaches have been developed in vitro and in vivo using phage-derived proteins as antibacterial agents. Finally, their use has also been widely considered for public health surveillance, as biosensor phages can be used to detect food and water contaminations and prevent bacterial epidemics. These novel approaches strongly promote the idea that phages and their proteins can be exploited as an effective weapon in the near future, especially in a world which is on the brink of a “postantibiotic era.”

16 November 2021 in Journal of Neural Transmission
Verified
Journal Article
Closed access
PDF file
MFMattia Ferro
Mattia Ferro
JLJacopo Lamanna
Jacopo Lamanna
Sara SpadiniSara Spadini
Sara Spadini
ANAlessio Nespoli
Alessio Nespoli
SSSimone Sulpizio
Simone Sulpizio
AMAntonio Malgaroli
Antonio Malgaroli

26 February 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
AMAndrea Moro
Andrea Moro
DSDaniele Saccenti
Daniele Saccenti
MFMattia Ferro
Mattia Ferro
SSSimona Scaini
Simona Scaini
AMAntonio Malgaroli
Antonio Malgaroli
JLJacopo Lamanna
Jacopo Lamanna
In decision making, the subjective value of a reward declines with the delay to its receipt, describing a hyperbolic function. Although this phenomenon, referred to as delay discounting (DD), has been extensively characterized and reported in many animal species, still, little is known about the neuronal processes that support it. Here, after drawing a comprehensive portrait, we consider the latest neuroimaging and lesion studies, the outcomes of which often appear contradictory among comparable experimental settings. In the second part of the manuscript, we focus on a more recent and effective route of investigation: non-invasive brain stimulation (NIBS). We provide a comprehensive review of the available studies that applied transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) to affect subjects’ performance in DD tasks. The aim of our survey is not only to highlight the superiority of NIBS in investigating DD, but also to suggest targets for future experimental studies, since the regions considered in these studies represent only a fraction of the possible ones. In particular, we argue that, based on the available neurophysiological evidence from lesion and brain imaging studies, a very promising and underrepresented region for future neuromodulation studies investigating DD is the orbitofrontal cortex.

31 October 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
MFMattia Ferro
Mattia Ferro
JLJacopo Lamanna
Jacopo Lamanna
MRMaddalena Ripamonti
Maddalena Ripamonti
GRGabriella Racchetti
Gabriella Racchetti
AAAlessandro Arena
Alessandro Arena
AMAntonio Malgaroli
Antonio Malgaroli
Ideally, elucidating the role of specific brain circuits in animal behavior would require the ability to measure activity at all involved synapses, possibly with unrestricted field of view, thus even at those boutons deeply located into the brain. Here, we introduce and validate an efficient scheme reporting synaptic vesicle cycling in vivo. This is based on SynaptoZip, a genetically encoded molecule deploying in the vesicular lumen a bait moiety designed to capture upon exocytosis a labeled alien peptide, Synbond. The resulting signal is cumulative and stores the number of cycling events occurring at individual synapses. Since this functional signal is enduring and measurable both online and ex post, SynaptoZip provides a unique method for the analysis of the history of synaptic activity in regions several millimeters below the brain surface. We show its broad applicability by reporting stimulus-evoked and spontaneous circuit activity in wide cortical fields, in anesthetized and freely moving animals.

1 April 2019 in Physiology & Behavior
Verified
Journal Article
Closed access
JLJacopo Lamanna
Jacopo Lamanna
SSSimone Sulpizio
Simone Sulpizio
MFMattia Ferro
Mattia Ferro
RMRiccardo Martoni
Riccardo Martoni
JAJubin Abutalebi
Jubin Abutalebi
AMAntonio Malgaroli
Antonio Malgaroli

1 October 2024 in Behavioral Sciences
Verified
Journal Article
Open access
PDF file
BBBianca Maria Benatti
Bianca Maria Benatti
AAAlice Adiletta
Alice Adiletta
PSPaola Sgadò
Paola Sgadò
AMAntonio Malgaroli
Antonio Malgaroli
MFMattia Ferro
Mattia Ferro
JLJacopo Lamanna
Jacopo Lamanna
Major depressive disorder (MDD) is a debilitating mental illness, and it is considered to be one of the leading causes of disability globally. The etiology of MDD is multifactorial, involving an interplay between biological, psychological, and social factors. Early life represents a critical period for development. Exposure to adverse childhood experiences is a major contributor to the global burden of disease and disability, doubling the risk of developing MDD later in life. Evidence suggests that stressful events experienced during that timeframe play a major role in the emergence of MDD, leading to epigenetic modifications, which might, in turn, influence brain structure, function, and behavior. Neuroplasticity seems to be a primary pathogenetic mechanism of MDD, and, similarly to epigenetic mechanisms, it is particularly sensitive to stress in the early postnatal period. In this review, we will collect and discuss recent studies supporting the role of epigenetics and neuroplasticity in the pathogenesis of MDD, with a focus on early life stress (ELS). We believe that understanding the epigenetic mechanisms by which ELS affects neuroplasticity offers potential pathways for identifying novel therapeutic targets for MDD, ultimately aiming to improve treatment outcomes for this debilitating disorder.